CSIMarket
 
Ironwood Pharmaceuticals inc   (NASDAQ: IRWD)
 

Ironwood Pharmaceuticals Inc's Suppliers Performance

IRWD's Supply Chain




 
IRWD Costs vs Sales of Suppliers Growth

• More on IRWD Suppliers






Ironwood Pharmaceuticals Inc's Comment on Supply Chain


The commercial suppliers of linaclotide API are responsible for producing the active pharmaceutical ingredient in compliance with Good Manufacturing Practices (GMP) and are subject to inspections and audits. AbbVie, Astellas, and AstraZeneca each manage linaclotide API, finished drug product, packaging, and distribution within their respective territories. For apraglutide, the company does not own manufacturing facilities but collaborates with contract development and manufacturing organizations (CDMOs) to produce clinical and potential commercial quantities. The company employs personnel experienced in managing these CDMOs. Apraglutide is currently supplied as a lyophilized powder for injection, with ongoing development of new drug presentations to improve patient convenience. Suppliers named across filings include AbbVie, AKP, Astellas, and AstraZeneca.

Ironwood Pharmaceuticals Inc's Comment on Supply Chain


The commercial suppliers of linaclotide API are responsible for producing the active pharmaceutical ingredient in compliance with Good Manufacturing Practices (GMP) and are subject to inspections and audits. AbbVie, Astellas, and AstraZeneca each manage linaclotide API, finished drug product, packaging, and distribution within their respective territories. For apraglutide, the company does not own manufacturing facilities but collaborates with contract development and manufacturing organizations (CDMOs) to produce clinical and potential commercial quantities. The company employs personnel experienced in managing these CDMOs. Apraglutide is currently supplied as a lyophilized powder for injection, with ongoing development of new drug presentations to improve patient convenience. Suppliers named across filings include AbbVie, AKP, Astellas, and AstraZeneca.







IRWD's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Ironwood Pharmaceuticals inc 690.45 389.32 129.87 100
SUBTOTAL 0.00 0.00 0.00 -


Sources: Ironwood Pharmaceuticals inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Ironwood Pharmaceuticals inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.